Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:55 AM
Ignite Modification Date:
2025-12-25 @ 12:55 AM
NCT ID:
NCT07300267
Eligibility Criteria:
Inclusion Criteria:
The main inclusion criteria include but are not limited to the following:
Stage 1:
* Is previously vaccinated with 3 routine infant doses of Pneumococcal 20-valent conjugate vaccine (PCV20)
* Is 12 through 15 months of age
Stage 2:
\- Is approximately 2 months of age
Both Stages:
* Was born at full term (gestational age greater than or equal to 37 weeks)
Exclusion Criteria:
The main exclusion criteria include but are not limited to the following:
Stage 1:
\- Has received a PCV dose at 10 months of age and older
Stage 2:
* Has received prior administration of any pneumococcal vaccine
Both stages:
* Has a history of invasive pneumococcal disease (IPD)
* Has a known hypersensitivity to any component of V118C or PCV20 including diphtheria toxoid
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
2 Months
Maximum Age:
15 Months
Study:
NCT07300267
Study Brief:
Protocol Section:
NCT07300267